Zika rewrites maternal immunization ethics
Conclusions: Our results provide novel insight into the transformation of knowledge, attitudes, and practice of community members and healthcare providers regarding Zika virus since its declaration as a public health emergency of international concern in 2016. PMID: 29348707 [PubMed - in process]
Zika virus (ZIKV), a mosquito-borne member of the Flaviviridae family, is the focus of a great public health concern due to its association with fetal malformation and neurologic disease. While ZIKV was previously limited to sporadic cases in Africa and Asia, but in the year 2015 it rapidly spread to Brazil and throughout the Americas and Caribbean causing 0.5 –1.5 million human infections [1–5]. Moreover, in 2016, due to the Olympic Games in Brazil, an increasing number of travelers from the Americas have been observed during the period of vector activity (May–November).
Date: Monday, 01 29, 2018; Speaker: Theresa MacPhail, PhD , Assistant Professor Science and Technology Studies, Stevens Institute of Technology; Building: Building 45 (Natcher Building); Videocast Event
January 23, 2018 1:00pm-2:00pm ET. This webinar will provide an overview of the 2017 Forces of Change findings, focused on four topic areas: Budget Cuts/Job Losses, Zika Prevention and Response, Multi-Sectoral Partnerships, and Workforce Recruitment.
AbstractMosquitos are responsible for a number of protozoal and viral diseases. Malaria, dengue, Japanese encephalitis (JE) and chikungunya epidemics occur commonly all over the world, leading to marked mortality and morbidity in children. Zika, Yellow fever and West Nile fever are others requiring prevention. Environmental control and mosquito bite prevention are useful in decreasing the burden of disease but vaccination has been found to be most cost-effective and is the need of the hour. RTS,S/AS01 vaccine is the first malaria vaccine being licensed for use againstP. falciparum malaria. Dengvaxia (CYD-TDV) against dengu...
Raj K. Singh, Kuldeep Dhama, Kumaragurubaran Karthik, Ruchi Tiwari, Rekha Khandia, Ashok Munjal, Hafiz M. N. Iqbal, Yashpal S. Malik, Rub én Bueno-Marí
Publication date: February 2018 Source:The Lancet Global Health, Volume 6, Issue 2 Author(s): Guilherme Sousa Ribeiro, Mariana Kikuti, Laura B Tauro, Leile Camila J Nascimento, Cristiane W Cardoso, Gúbio S Campos, Albert I Ko, Scott C Weaver, Mitermayer G Reis, Uriel Kitron
CONCLUSION: Our results suggest that the yearly risk of collecting a RRV-infected blood donation in Australia is low and is at the lower range of previous risk modeling. The majority of Australian donor centers were not in areas known to be at the highest risk for RRV transmission, which was not taken into account in previous models based on notification data. Therefore, we believe that the risk of RRV transfusion transmission in Australia is acceptably low and appropriately managed through existing risk management, including donation restrictions and recall policies. PMID: 29350414 [PubMed - as supplied by publisher]
NIH-funded study observes virus-induced placental damage in monkeys.
(Oregon Health&Science University) New researcher shows how Zika virus infection in five pregnant rhesus monkeys caused placental tissues to become thickened and inflamed, resulting in less oxygen being transported across the placenta and to the baby.